ADMA Biologics Files Q1 2025 10-Q Report
Ticker: ADMA · Form: 10-Q · Filed: May 7, 2025 · CIK: 1368514
| Field | Detail |
|---|---|
| Company | Adma Biologics, Inc. (ADMA) |
| Form Type | 10-Q |
| Filed Date | May 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, biologics
TL;DR
ADMA BIOLOGICS filed its 10-Q for Q1 2025. All systems go.
AI Summary
ADMA Biologics, Inc. filed its quarterly report on Form 10-Q for the period ending March 31, 2025. The company, incorporated in Delaware, is involved in the biological products sector. Its principal executive offices are located in Ramsey, New Jersey.
Why It Matters
This filing provides investors with an update on ADMA Biologics' financial performance and operational status for the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial and operational information.
Key Players & Entities
- ADMA BIOLOGICS, INC. (company) — Registrant
- March 31, 2025 (date) — Quarterly period end date
- 001-36728 (other) — Commission file number
- Ramsey, New Jersey (location) — Principal executive offices location
FAQ
What is the primary business of ADMA Biologics, Inc.?
ADMA Biologics, Inc. is primarily involved in the biological products sector, specifically biological products (no diagnostic substances).
When was the quarterly period covered by this 10-Q filing?
The quarterly period covered by this 10-Q filing ended on March 31, 2025.
What is the company's commission file number?
The company's commission file number is 001-36728.
Where are ADMA Biologics, Inc.'s principal executive offices located?
ADMA Biologics, Inc.'s principal executive offices are located at 465 State Route 17, Ramsey, New Jersey 07446.
What is the state of incorporation for ADMA Biologics, Inc.?
ADMA Biologics, Inc. is incorporated in Delaware.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 7, 2025 regarding ADMA BIOLOGICS, INC. (ADMA).